Nanoparticle-based radiosensitization strategies for improving radiation therapy
- PMID: 36873996
- PMCID: PMC9977822
- DOI: 10.3389/fphar.2023.1145551
Nanoparticle-based radiosensitization strategies for improving radiation therapy
Abstract
Radiotherapy remains the mainstay treatment for a variety of cancer forms. However, the therapeutic efficiency of radiation is significantly limited by several aspects, including high radiation resistance caused by low reactive oxygen species concentrations and a low absorption rate of radiation by tumor tissue, inappropriate tumor cell cycle and tumor cell apoptosis, and serious radiation damage to normal cells. In recent years, nanoparticles have been widely used as radiosensitizers due to their unique physicochemical properties and multifunctionalities for potentially enhancing radiation therapy efficacy. In this study, we systematically reviewed several nanoparticle-based radiosensitization strategies for radiation therapy use, including designing nanoparticles that upregulate the levels of reactive oxygen species, designing nanoparticles that enhance the radiation dose deposit, designing chemical drug-loaded nanoparticles for enhancing cancer cell sensitivity to radiation, designing antisense oligonucleotide gene-loaded nanoparticles, and designing nanoparticles using a unique radiation-activable property. The current challenges and opportunities for nanoparticle-based radiosensitizers are also discussed.
Keywords: antisense oligonucleotide gene; chemical drugs; nanoparticle strategy; radiation dose deposit; radiation-activable property; radiosensitizers; radiotherapy; reactive oxygen species.
Copyright © 2023 Shen, Huang and Jiang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Delivery of Nanoparticle-Based Radiosensitizers for Radiotherapy Applications.Int J Mol Sci. 2019 Dec 31;21(1):273. doi: 10.3390/ijms21010273. Int J Mol Sci. 2019. PMID: 31906108 Free PMC article. Review.
-
The effect of nanoparticle coating on biological, chemical and biophysical parameters influencing radiosensitization in nanoparticle-aided radiation therapy.BMC Chem. 2023 Dec 11;17(1):180. doi: 10.1186/s13065-023-01099-7. BMC Chem. 2023. PMID: 38082361 Free PMC article. Review.
-
Enhancement of radiosensitization by metal-based nanoparticles in cancer radiation therapy.Cancer Biol Med. 2014 Jun;11(2):86-91. doi: 10.7497/j.issn.2095-3941.2014.02.003. Cancer Biol Med. 2014. PMID: 25009750 Free PMC article. Review.
-
The dependence of radio-sensitization efficiency on mitochondrial targeting with NaGdF4:Yb,Er nanoparticles.Acta Biomater. 2021 Sep 1;131:508-518. doi: 10.1016/j.actbio.2021.06.041. Epub 2021 Jun 29. Acta Biomater. 2021. PMID: 34214663
-
Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy.Int J Nanomedicine. 2020 Nov 24;15:9407-9430. doi: 10.2147/IJN.S272902. eCollection 2020. Int J Nanomedicine. 2020. PMID: 33262595 Free PMC article. Review.
Cited by
-
Enhancing Proton Therapy Efficacy Through Nanoparticle-Mediated Radiosensitization.Cells. 2024 Nov 7;13(22):1841. doi: 10.3390/cells13221841. Cells. 2024. PMID: 39594590 Free PMC article. Review.
-
Precision radiotherapy with molecular-profiling of CNS tumours.J Neurooncol. 2025 Mar;172(1):51-75. doi: 10.1007/s11060-024-04911-z. Epub 2024 Dec 19. J Neurooncol. 2025. PMID: 39699761 Review.
-
Quercetin regulates sensitivity to X-ray radiation of hepatocellular carcinoma through miR-216a-3p.Biomol Biomed. 2025 Mar 7;25(4):833-849. doi: 10.17305/bb.2024.11125. Biomol Biomed. 2025. PMID: 39508798 Free PMC article.
-
The application of radionuclide therapy for breast cancer.Front Nucl Med. 2024 Jan 10;3:1323514. doi: 10.3389/fnume.2023.1323514. eCollection 2023. Front Nucl Med. 2024. PMID: 39355029 Free PMC article. Review.
-
Recent Progress of Nanomedicine for the Synergetic Treatment of Radiotherapy (RT) and Photothermal Treatment (PTT).Cancers (Basel). 2025 Jul 10;17(14):2295. doi: 10.3390/cancers17142295. Cancers (Basel). 2025. PMID: 40723179 Free PMC article. Review.
References
-
- Choi J. W., Kim H.-C., Baek S. Y., Ryu Y. J., Chung J. W. (2015). A metastatic hepatoma model of rats using the 13762-MAT-B-III cell line: Basic characteristics and potential as a tool for interventional oncology experiments. Anticancer Res. 35 (3), 1333–1338. - PubMed
Publication types
LinkOut - more resources
Full Text Sources